Is Control Bionics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Control Bionics Ltd (CBL.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Control Bionics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Control Bionics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Control Bionics Ltd?

Muslim investors may consider investing in Control Bionics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Control Bionics Ltd classified as HALAL?

Musaffa determines the Shariah status of Control Bionics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Control Bionics Ltd updated?

The Shariah compliance status of Control Bionics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Control Bionics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Control Bionics Ltd?

You can check the latest Shariah compliance status of Control Bionics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CBL.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 30, 2025

Report Source: 2025 2nd Quarter Report

Control Bionics Ltd. Stock Analysis CBL.AX

Australia Health Care Nano Cap Report: Q2, 2025

Control Bionics Ltd. engages in the manufacture, design, and sale of wireless wearable electromyography (EMG) based augmentative and alternative communication (AAC) technology. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. The company is commercializing its advancement in its technology, NeuroStrip. The company is focused on neuromuscular rehabilitation and athletic optimization.

Key Statistics of Control Bionics Ltd (CBL.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.06AUD0.06

Today's Open

AUD0.06

Volume

316.60K

P/E Ratio (TTM)

52 Week Range

AUD0.03AUD0.09

Market Cap

23.07M

Avg. Volume

136.10K

Dividend Yield

Financial Metrics & Statements of Control Bionics Ltd (CBL.AX)

FAQ's for Control Bionics Ltd (CBL.AX)

According to Musaffa’s Shariah screening methodology, Control Bionics Ltd (CBL.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.